PLAU and Miyoshi myopathy: The results showed that miR-23, a microRNA molecule that may act on the 3’UTR of uPA, had an opposite expression trend in MM specimens from that in uPA: it was highest intraosseous specimens and lowest in extra-bone tumor samples (Figure 3C).